Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares
RMEAX
NASDAQ
Weiss Ratings | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Good | |||
Risk Grade | B | |||
Company Info | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Aspiriant | |||
Manager/Tenure (Years) | Ran Leshem (10), John Allen (9), Marc Castellani (9), 7 others | |||
Website | http://www.aspiriantfunds.com | |||
Fund Information | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares | |||
Category | Global Large-Stock Blend | |||
Sub-Category | Global Equity Large Cap | |||
Prospectus Objective | World Stock | |||
Inception Date | Apr 04, 2013 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 1.36% | |||
Dividend | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 2.12% | |||
Asset Allocation | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 2.29% | |||
Stock | 83.71% | |||
U.S. Stock | 54.27% | |||
Non-U.S. Stock | 29.44% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.03% | |||
Convertible | 0.00% | |||
Other Net | 13.97% | |||
Price History | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.75% | |||
30-Day Total Return | 3.38% | |||
60-Day Total Return | 5.66% | |||
90-Day Total Return | 8.67% | |||
Year to Date Total Return | 8.60% | |||
1-Year Total Return | 11.24% | |||
2-Year Total Return | 31.71% | |||
3-Year Total Return | 46.42% | |||
5-Year Total Return | 62.26% | |||
Price | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $16.79 | |||
1-Month Low NAV | $16.23 | |||
1-Month High NAV | $16.79 | |||
52-Week Low NAV | $14.33 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $17.16 | |||
52-Week High Price (Date) | Dec 09, 2024 | |||
Beta / Standard Deviation | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.70 | |||
Standard Deviation | 10.66 | |||
Balance Sheet | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 1.36B | |||
Operating Ratios | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.98% | |||
Turnover Ratio | 19.00% | |||
Performance | RMEAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 11.52% | |||
Last Bear Market Total Return | -9.20% | |||